Peer Review History
Original SubmissionMarch 27, 2024 |
---|
PDIG-D-24-00116 Diagnostic Accuracy of a Smartphone-Based Device (VistaView) for Detection of Diabetic Retinopathy: A Prospective Study PLOS Digital Health Dear Dr. Siddiqui, Thank you for submitting your manuscript to PLOS Digital Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Digital Health's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript within 60 days Sep 07 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at digitalhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pdig/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: * A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. * A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. * An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. We look forward to receiving your revised manuscript. Kind regards, Luis Filipe Nakayama, M.D. Academic Editor PLOS Digital Health Journal Requirements: 1. We ask that a manuscript source file is provided at Revision. Please upload your manuscript file as a .doc, .docx, .rtf or .tex. 2. Please provide separate figure files in .tif or .eps format. For more information about figure files please see our guidelines: LINK https://journals.plos.org/digitalhealth/s/figures https://journals.plos.org/digitalhealth/s/figures#loc-file-requirements Additional Editor Comments (if provided): Review of “Diagnostic Accuracy of a Smartphone-Based Device (VistaView) for Detection of Diabetic Retinopathy: A Prospective Study” * I suggest a review of English and text flow. * Line 162: Is 59 the mean age of the males specifically or the overall cohort? * Comorbidities: Are there any reported comorbidities among the participants? * Capturing Protocol: What was the image-capturing protocol? Was it 1 image or 2 images per eye? * How was the issue of a single bad-quality image in a set handled? * How was the labeling performed—at the image level, eye level, or patient level? * Referable Criteria: Please clarify the referable criteria. Is it ICDR >1 and/or macular edema? * Handling Low-Quality Images: How were low-quality images managed between devices for statistical analysis? * It would be beneficial to describe the quality parameters across demographics, diabetic retinopathy (DR), and maculopathy severity between devices. * I suggest reporting the results for the ICDR scores grading between the devices, as the labeling grading was conducted instead of just any DR and Referable DR. * Image Quality Reporting: Why were image quality reports done by individual graders instead of by consensus and adjudication, as with DR scores? * False Positives and False Negatives: Please report the false positive and false negative rates for each classification. * Additionally, I recommend including a statistical analysis to compare the performance of the devices, demographic, and associated factors. * How do you justify the low low sensitivity of this device? I suggest expanding the discussion. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Does this manuscript meet PLOS Digital Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented. Reviewer #1: Partly Reviewer #2: Partly -------------------- 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No -------------------- 3. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes -------------------- 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS Digital Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes -------------------- 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Shahzad and colleagues present an interesting and well-written manuscript entitled "Diagnostic Accuracy of a Smartphone-Based Device (VistaView) for Detection of Diabetic Retinopathy: A Prospective Study". The authors conducted a prospective cohort study comparing the diagnostic accuracy of a handheld smartphone based fundus camera in screening for diabetic retinopathy against the gold standard, a standard table-top camera. Sensitivities of around 70% and specificities of about 90% were found. The inter-observer agreement was markedly lower for the handheld camera, as well as the proportion of ungradeable images. Overall this is a rigourosly conducted study and the topic is timely and relevant. The findings are important for the scientific community. A few issues should be addressed before the paper can be evaluated further: 1) Although the sensitivities found by the authors are lower than the recommended 80%, the authors conclude that "The vistaview offers high diagnostic accuracy for DR screening and can be used as a screening tool in LMIC". This conclusion is not based on the data. Please reconsider. 2) The sensitivities reported here are lower than for other handheld cameras in the literature. Please discuss. 3) The discussion is a bit lengthy and could be shortened. 4) Suggest to present the results on image gradeability before the accuracy data. 5) The manuscript would benefit from native speaker English review. Reviewer #2: The objective of this article is to evaluate the diagnostic accuracy of VistaView in the screening of diabetic retinopathy (DR). This clarity helps readers quickly grasp the core content and research focus of the article. The article employs scientific research methods, including a prospective study design, reasonable sample selection, and accurate evaluation indicators. The selection of these methods ensures the reliability and effectiveness of the study. After a careful reading and review of the full text of the paper, the reviewer proposes the following comments: 1. Add a Detailed Description of the Research Object: It is recommended to add a detailed description of the research object in the research methods section, including key information such as inclusion and exclusion criteria, so that readers can have a more comprehensive understanding of the characteristics and representativeness of the research object. 2. Discuss the Limitations and Future Directions of the Research: In the discussion section, it is recommended that the author discuss the limitations of this study and possible future research directions. For example, the applicability of VistaView in different populations, comparative studies with other screening tools, and DR screening methods based on artificial intelligence technology can be explored. This helps readers to have a more comprehensive understanding of the value and significance of this study and provides useful references for future research. 3. All Subjects Underwent Mydriasis for Standard Color Fundus Photography: What is the significance of mydriasis? What is the value of promoting this method? 4. Clarification of "Maculopathy": Does “Maculopathy” refer to diabetic macular edema (DME) or does it include all macular lesions? 5. Terminology: The term “colour fundus photography” should not be abbreviated to “fundus photography.” -------------------- 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public. For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Weihua Yang -------------------- [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 1 |
Diagnostic Accuracy of a Smartphone-Based Device (VistaView) for Detection of Diabetic Retinopathy: A Prospective Study PDIG-D-24-00116R1 Dear Dr. Siddiqui, We are pleased to inform you that your manuscript 'Diagnostic Accuracy of a Smartphone-Based Device (VistaView) for Detection of Diabetic Retinopathy: A Prospective Study' has been provisionally accepted for publication in PLOS Digital Health. Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow-up email from a member of our team. Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated. IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact digitalhealth@plos.org. Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Digital Health. Best regards, Luis Filipe Nakayama, M.D. Academic Editor PLOS Digital Health *********************************************************** All my comments have been successfully addressed. Reviewer Comments (if any, and for reference): Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Does this manuscript meet PLOS Digital Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS Digital Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: I am satisfied with the authors’ corrections. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public. For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Weihua Yang ********** |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .